This role supports the development and execution of the US Medical Affairs strategy for encaleret across clinical development programs including autosomal dominant hypocalcemia type 1 and chronic hypoparathyroidism.
Base: $180,600 - $280,000 USD; Bonus/Equity: Annual performance bonus and company equity included; Benefits: Generous health benefits offered
Must-have
Nice-to-have
Not specified